About SEEKIN INC.
SeekIn Inc. is a biotech company founded in 2017, focusing on blood-based pan-cancer early detection using next-generation sequencing and artificial intelligence. The company aims to reduce cancer mortality rates by 15% through early detection and has developed solutions for cancer screening, recurrence monitoring, and treatment response evaluation.
Blood-based pan-cancer early detectionNext-generation sequencing (NGS) technologyArtificial intelligence-powered cancer risk assessmentPost-surgical recurrence monitoringTreatment response evaluationDevelopment of molecular tests for leukemia patientsCancer early detection technology for canines
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SEEKIN INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.